Price to Sales ratio Analysis of Tekla Healthcare Investors - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY PS
Period Ending - Sep-23

14.09


Very Poor PS
Period Ending - Sep-22
-3.83

Very Poor PS
Growth
467.86 %
Trailing Twelve Months PS
Period Ending - Sep-23

9.73


Very Poor PS
PS Analysis of Tekla Healthcare Investors
P/S Ratio of Tekla Healthcare Investors with value of 9.73 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of HQH rose handsomely by 467.86 % this year.
PS Ratio with value of 14.09 was highest in Year Sep-23 in last Five Years.
PS Ratio with value of -4.75 was lowest in Year Sep-19 in last Five Years.
Latest PS Ratio with value of 14.09 is Greater than Average PS of 2.64 in last five years.
Other PS Related Info of HQH that may interest you.
Tekla Healthcare Investors Overview
CodePricePrevious PricePrice ChangeSector
HQH16.5616.4 0.976 % Asset Management
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Very Low Value Stock
FY - Historical Price to Sales of Tekla Healthcare Investors
PeriodSep-23Sep-22Sep-21Sep-20Sep-19Sep-18Sep-17
PS14.09-3.834.693.02-4.7510.555.46
Change467.86 %-181.71 %55.34 %163.58 %-144.96 %93.35 %-95.94 %
You are view first 7 Records. Log in to view all 27 in Premium view
FY Chart of Price to Sales of Tekla Healthcare Investors


Note : All Data Generated at the End of Trading Hours (EOD Data)